Management will announce the final results for the year ended 31 May 2022.

Management will hold the company’s AGM meeting at 2pm on 27^th July 2022 relating to the final results for the year ended 31 December 2021.

The company is pleased to announce a trading update for the year ended 30 June 2022.

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on 3.00pm on 19 July 2022 to discuss the Company’s rail operations and future opportunities.

Investors can sign up to Investor Meet Company for free, by clicking here

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, at 4:30pm on 30 Jun 2022 relating to the final results for the year ended 31 December 2021.

Investors can sign up to Investor Meet Company for free, by clicking here

Management will report its third quarter fiscal 2022 financial results

Hosting a Capital Markets Day for investors on Wednesday 11th May 2022. 

Analysts and institutional investors are welcome to attend the event in the City of London. Due to restrictions on numbers, it will not be possible for all interested parties to attend in-person, however, a webcast will be made available for retail investors and others to view the presentations live. 

The event will provide investors with a compelling opportunity to hear more from other senior members of the management team about the Company's three business segments, with a particular focus on its German Joint Venture, Hargreaves Raw Materials Services GmbH ("HRMS") and the portion of the land portfolio which is earmarked for use by renewable energy suppliers within its property business, Hargreaves Land.

Hosting a Capital Markets Day for investors on Tuesday 26 April 2022. The event will provide investors with a compelling opportunity to hear more from other senior members of the management team about the roadmap and growth plans for certain products and services, both in North America and internationally, as well as perspectives on the dynamics within the molecular diagnostics market and the scope for growing the Company's genomic services business.

To register your interest please contact Walbrook PR on 020 7933 8780 or email [email protected].

Event information: Management will present the Company's Interim Results at an in-person investor presentation on Monday 21 February 2022. For those that are unable to attend, a live webcast of the investor briefing will be broadcast.